Patients with short bowel syndrome have a high mortality rate that is mainly attributed to
complications from central lines and long-term intravenous (IV) nutrition. There are few
medical therapies to date that improve gut absorption in patients with short bowel syndrome.
The primary objective of this study is to evaluate if absorption from the GI tract improves
in subjects with short bowel syndrome following therapy with pancreatic enzymes.